RADHAKRISHNAN Lab

Radhakrishnan Lab at Yale

Using Positron Emission Tomography (PET) imaging to elucidate the neurobiological link between cannabinoids and psychiatric disorders

Rajiv Radhakrishnan, MBBS, MD, FAPARajiv Radhakrishnan, MBBS, MD, FAPA is an Assistant Professor of Psychiatry at Yale School of Medicine

Principal Investigator (PI)

Rajiv Radhakrishnan, MBBS, MD

Dr. Radhakrishnan is an Assistant Professor of Psychiatry at Yale University School of Medicine. As a physician-scientist with expertise in using PET imaging understand the neurobiological link between cannabinoids and psychiatric disorders, he dedicates most of his time towards research while also contributing to clinical care of patients at Yale New Haven Psychiatric Hospital (YPH). He completed psychiatry residency training at Yale Psychiatry Residency program in 2016 followed by an Advanced Schizophrenia Research Fellowship in 2018; and is double boarded in Psychiatry (ABPN) and Addiction Medicine (ABPM). He has more than 50 publications and a strong academic track-record. Among his many accolades, he received the 2018 YCCI Scholar award, a CTSA KL2 career award, to examine the effect of antipsychotics on inflammation and microglial activation using [11C]PBR28 PET. He is also the recipient of 2015-16 Thomas P. Detre Fellowship in Translational Neuroscience Research for a pilot study to measure synaptic density in schizophrenia using a novel PET tracer, [11C] UCB-J, and the 2016 Dana Foundation’s David Mahoney Neuroimaging Program award to continue this work.

Bio: https://medicine.yale.edu/profile/rajiv_radhakrishnan/

Scholar metrics: https://scholar.google.com/citations?user=8D54wikAAAAJ&hl=en&oi=ao

Research Assistants

Rachel HirdRachel Hird is a Research Assistant 2 HSS at Yale School of Medicine

Collaborators

Richard Carson, PhDRichard E. Carson received his Ph.D. from UCLA in 1983 in Biomathematics. From that time on, he has focused his research on the development and application of mathematical techniques for the study of human beings and non-human primates with Positron Emission Tomography (PET), a noninvasive imaging technology that uses

Deepak Cyril Dsouza, MBBS, MDDeepak Cyril D’Souza, MD is a Professor of Psychiatry, Yale University School of Medicine and a staff psychiatrist at VA Connecticut Healthcare System (VACHS).

Mohini Ranganathan, MBBS

Kelly Cosgrove, PhDDr. Cosgrove uses positron emission tomography (PET) to gain insights into the brains of people after they’ve stopped using alcohol and tobacco. Trained as a clinical psychologist who worked with individuals suffering from drug addiction, Dr. Cosgrove transitioned to conducting research in order to find more effective

Yiyun Huang, PhD

David Matuskey, MDI am a board certified psychiatrist and neuropsychiatrist with research work that has been translational in nature and focused on elucidating the underlying pathology of neuropsychiatric conditions such as Autism Spectrum Disorder, substance abuse and neuropsychiatric disorders (e.g., Parkinson's and

Albert Perrino Jr, MDDr. Albert Perrino is the Director of Anesthesiology for Veterans Affairs Healthcare. After receiving his medical degree from the University of Pennsylvania in 1984, Dr. Perrino completed both an Anesthesia residency and a fellowship in Anesthesia at Yale New Haven Hospital. In 1988, Dr. Perrino officially joined the

Samuel Wilkinson, MDSamuel Wilkinson, MD is an Associate Professor of Psychiatry at Yale School of Medicine

Jack Tsai, PhDDr. Tsai currently serves as Campus Dean and Professor of Public Health at UTHealth, and also as Research Director for the U.S. Department of Veterans Affairs (VA) National Center on Homelessness Among Veterans. He served as full-time faculty at Yale School of Medicine for a decade where he was Director of the Division

Sinan Guloksuz, MD, PhD

Jim van Os - Research at UMC UtrechtI have a background in Epidemiology (London School of Hygiene and Tropical Medicine) and Psychiatry (Institute of Psychiatry, King’s College London). My research has focused on elucidating the nature of mental variation in relation to context, and identifying the interactions between environment and genetic liability driving this variation. Over the course of my career, I […]

Page updated

Google Sites

Report abuse